4//SEC Filing
KOS PHARMACEUTICALS INC 4
Accession 0001248149-04-000001
CIK 0001018952operating
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 4:29 PM ET
Size
14.6 KB
Accession
0001248149-04-000001
Insider Transaction Report
Form 4
JAHARIS MICHAEL
Director10% Owner
Transactions
- Conversion
Common Stock, $.01 par value
2003-12-31$4.91/sh+5,091,650$25,000,002→ 5,111,651 total - Conversion
Common Stock, $.01 par value
2003-12-31$4.91/sh+3,841,650$18,862,502→ 3,841,650 total(indirect: By Wilson Point Holdings, LP) - Conversion
$25 Million Convertible Note
2003-12-31(indirect: By Wilson Point Holdings, LP)Exercise: $4.91Exp: 2003-12-31→ Common Stock (3,841,650 underlying)
Holdings
- 960,069(indirect: See footnote 4.)
Common Stock, $.01 par value
- 44,227(indirect: By Spouse)
Common Stock, $.01 par value
- 7,610,000(indirect: See footnote 3.)
Common Stock, $.01 par value
Footnotes (6)
- [F1]These shares are owned directly by Wilson Point Holdings, LP ("Wilson Point"). Mary Jaharis, the reporting person's spouse, as the sole manager of Cubs Management, LLC ("Cubs Management"), a Delaware limited liability company that is the sole general partner of Wilson Point, has sole voting and dispositive power with respect to these shares. Michael Jaharis disclaims beneficial ownership of all securities held or beneficially owned, direclty or indirectly, by Cubs Management and Wilson Point, and this report should not be deemed an admission that Michael Jaharis is the beneficial owner of such securities for purpose of Section 16 or for any other purpose.
- [F2]Includes one share held jointly with Michael Jaharis' spouse.
- [F3]Michael Jaharis is the indirect controlling shareholder of the corporation that owns such securities.
- [F4]Michael Jaharis is the controlling shareholder of the corporation that owns such securities.
- [F5]Michael Jaharis disclaims beneficial ownership of all securities held or beneficially owned, directly or indirectly, by Michael Jaharis' spouse, and this report should not be deemed an admission that Michael Jaharis is the beneficial owner of such securities for purposes of Section 16 or any other purpose.
- [F6]The convertible note is immediately exercisable.
Documents
Issuer
KOS PHARMACEUTICALS INC
CIK 0001018952
Entity typeoperating
IncorporatedFL
Related Parties
1- filerCIK 0001018952
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 4:29 PM ET
- Size
- 14.6 KB